Fate Therapeutics to present CAR T-cell therapy data at medical conferences

Go back to Fate Therapeutics to present CAR T-cell therapy data at medical conferences
FATE THERAPEUTICS (NASDAQ: FATE) Delayed: 2.15 +0.06 (2.87%)
Previous Close $2.09    52 Week High $4.76 
Open $2.07    52 Week Low $1.46 
Day High $2.23    P/E N/A 
Day Low $2.01    EPS $-1.91 
Volume 5,698,136